Shouman Wang

759 total citations
29 papers, 342 citations indexed

About

Shouman Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shouman Wang has authored 29 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Shouman Wang's work include RNA modifications and cancer (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shouman Wang is often cited by papers focused on RNA modifications and cancer (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Shouman Wang collaborates with scholars based in China. Shouman Wang's co-authors include Zhi Xiao, Lili Tang, Feiyu Chen, Nianhua Ding, Jun Wang, Xinwu Guo, Lizhong Dai, Xue Dong, Limin Peng and Juan Huang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Shouman Wang

29 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shouman Wang China 12 159 154 111 49 48 29 342
Weifang Zhang China 12 117 0.7× 209 1.4× 84 0.8× 49 1.0× 39 0.8× 33 355
Abhilasha Sinha United States 12 134 0.8× 188 1.2× 55 0.5× 46 0.9× 72 1.5× 17 300
Cigdem Ussakli United States 8 155 1.0× 111 0.7× 73 0.7× 72 1.5× 26 0.5× 10 308
Daisaku Ashikari Japan 9 72 0.5× 218 1.4× 83 0.7× 84 1.7× 89 1.9× 13 345
Jinjing Tan China 11 104 0.7× 176 1.1× 123 1.1× 36 0.7× 36 0.8× 28 295
Yuxiang Chen China 10 154 1.0× 166 1.1× 132 1.2× 42 0.9× 58 1.2× 26 367
Tania Rossi Italy 11 150 0.9× 208 1.4× 127 1.1× 44 0.9× 40 0.8× 25 322
Tai Qin China 9 164 1.0× 129 0.8× 95 0.9× 75 1.5× 34 0.7× 13 303
Tomomi Ueki Japan 8 149 0.9× 245 1.6× 54 0.5× 45 0.9× 23 0.5× 10 385

Countries citing papers authored by Shouman Wang

Since Specialization
Citations

This map shows the geographic impact of Shouman Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouman Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouman Wang more than expected).

Fields of papers citing papers by Shouman Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shouman Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouman Wang. The network helps show where Shouman Wang may publish in the future.

Co-authorship network of co-authors of Shouman Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shouman Wang. A scholar is included among the top collaborators of Shouman Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shouman Wang. Shouman Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Wenlong, Ying Ding, Hui Zhao, et al.. (2025). NSUN2–tRNAVal−CAC-axis-regulated codon-biased translation drives triple-negative breast cancer glycolysis and progression. Cellular & Molecular Biology Letters. 30(1). 100–100. 2 indexed citations
2.
Liu, Shilei, Sai Zhang, Liqiu Liao, et al.. (2024). Research progress on the multi-omics and survival status of circulating tumor cells. Clinical and Experimental Medicine. 24(1). 49–49. 7 indexed citations
3.
Ding, Nianhua, Jian Pang, Xuan Liu, et al.. (2024). Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial. Breast Cancer Research. 26(1). 9–9. 3 indexed citations
4.
Peng, Jing, Qitong Chen, Danhua Zhang, et al.. (2024). Comparison of neoadjuvant chemotherapy response and prognosis between HR-low/HER2-negative BC and TNBC: an exploratory real-world multicentre cohort study. Frontiers in Endocrinology. 15. 1347762–1347762. 1 indexed citations
5.
Zhou, Zhiyang, Yukun Cao, Yuan Yang, Shouman Wang, & Feiyu Chen. (2023). METTL3-mediated m 6 A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis. Epigenetics. 18(1). 2217033–2217033. 11 indexed citations
6.
Chen, Wanxin, et al.. (2023). A pilot study on pyroptosis related genes in peripheral blood mononuclear cells of non-small cell lung cancer patients. BMC Pulmonary Medicine. 23(1). 6 indexed citations
7.
Wang, Xiaobo, et al.. (2022). Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer. Cancer Science. 114(5). 2041–2052. 5 indexed citations
8.
Hu, Huiyu, Nianhua Ding, Haiyan Zhou, et al.. (2021). A novel CD74-ROS1 gene fusion in a patient with inflammatory breast cancer: a case report. Journal of Medical Case Reports. 15(1). 277–277. 2 indexed citations
9.
Pang, Jian, Haiyan Zhou, Xue Dong, Shouman Wang, & Zhi Xiao. (2021). Relationship Between the Neutrophil to Lymphocyte Ratio, Stromal Tumor-infiltrating Lymphocytes, and the Prognosis and Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. Clinical Breast Cancer. 21(6). e681–e687. 13 indexed citations
10.
Huang, Juan, Shouman Wang, Yuhui Wu, et al.. (2021). Conventional suture with prolonged timing of drainage is as good as quilting suture in preventing seroma formation at pectoral area after mastectomy. World Journal of Surgical Oncology. 19(1). 148–148. 5 indexed citations
11.
12.
13.
14.
Zeng, Feng, Jianfu Heng, Xinwu Guo, et al.. (2020). The novel TP53 3′-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection. Breast Cancer Research and Treatment. 180(1). 237–245. 3 indexed citations
15.
16.
Li, Guoli, Xinwu Guo, Ming Chen, et al.. (2018). Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients. PLoS ONE. 13(9). e0203495–e0203495. 33 indexed citations
17.
Wang, Shouman, Lili Tang, & Feiyu Chen. (2015). ASTRAGALOSIDE III FROM ASTRAGALUS MEMBRANACEUS ANTAGONIZES BREAST CANCER GROWTH. African Journal of Traditional Complementary and Alternative Medicines. 12(3). 5 indexed citations
18.
Li, Zibo, Xinwu Guo, Shengyun Li, et al.. (2015). Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients. Breast Cancer Research and Treatment. 149(3). 767–779. 49 indexed citations
19.
Wang, Shouman, Feiyu Chen, & Lili Tang. (2014). IL-32 promotes breast cancer cell growth and invasiveness. Oncology Letters. 9(1). 305–307. 31 indexed citations
20.
Xiao, Zhi, Nianhua Ding, Guiqing Xiao, et al.. (2012). Reversal of Multidrug Resistance by Gefitinib Via RAF1/ERK Pathway in Pancreatic Cancer Cell Line. The Anatomical Record. 295(12). 2122–2128. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weifang Zhang Breakdown of academic impact, for papers by Abhilasha Sinha Breakdown of academic impact, for papers by Cigdem Ussakli Breakdown of academic impact, for papers by Daisaku Ashikari Breakdown of academic impact, for papers by Jinjing Tan Breakdown of academic impact, for papers by Yuxiang Chen Breakdown of academic impact, for papers by Tania Rossi Breakdown of academic impact, for papers by Tai Qin Breakdown of academic impact, for papers by Tomomi Ueki
Rankless by CCL
2026